Diffuse Amplified Musculoskeletal Pain Syndromes (AMPS) represent a spectrum of conditions characterized by centralized pain amplification, widespread pain distribution, and functional impairment that is disproportionate to objective findings. AMPS includes Complex Regional Pain Syndrome (CRPS) in children and other forms of chronic pain with amplification mechanisms.

These conditions affect 5-15% of children presenting with chronic pain complaints and are associated with significant disability, school avoidance, and psychological comorbidity. Early recognition and interdisciplinary intervention are essential for optimal outcomes.

AMPS involves multiple interconnected mechanisms:

• Central sensitisation: Amplification of nociceptive signaling at spinal and supraspinal levels, resulting in heightened pain perception
• Autonomic dysfunction: Sympathetic hyperactivity with abnormal vascular and sudomotor responses
• Neuroinflammation: Glial activation and altered neurotransmitter function in pain-processing pathways
• Psychosocial factors: Anxiety, depression, trauma, maladaptive pain beliefs, and family dynamics contribute significantly
• Loss of inhibitory control: Decreased effectiveness of descending pain modulation pathways

The condition is NOT psychosomatic but represents genuine neurobiological changes in pain processing. Psychological factors contribute to pathogenesis but do not cause the condition.

Characteristic features include:

• Allodynia: Pain from normally non-painful stimuli (light touch, temperature changes)
• Hyperalgesia: Exaggerated pain response to painful stimuli
• Widespread distribution: Pain involving multiple body regions (not just original injury site)
• Functional limitation: Marked restriction of activities, mobility, and participation
• School avoidance: Significant school absence and educational impact
• Disproportionate severity: Symptoms far exceed findings on examination and investigations
• Psychological comorbidity: Depression, anxiety, trauma history common
• Sleep disturbance: Insomnia contributing to pain amplification
• Temperature and color changes: In CRPS subtypes (edema, skin changes, vasomotor instability)

Essential investigations to exclude organic disease:

• Full blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)
• Biochemistry profile (electrolytes, liver and renal function)
• Inflammatory markers: normal in AMPS (key finding)

Imaging:

• Plain radiographs: typically normal or show only soft tissue swelling
• MRI: normal structural findings; may show diffuse edema in acute phase
• Bone scintigraphy: non-specific; not routinely recommended

Diagnostic criteria: Budapest criteria for CRPS require pain disproportionate to injury, sensory dysfunction, vasomotor changes, and absence of other conditions explaining symptoms.

Key finding: Normal or near-normal inflammatory markers and imaging differentiate AMPS from organic rheumatological or inflammatory conditions.

Intensive interdisciplinary approach:

• Physiotherapy: Graded exercise, functional restoration, desensitization techniques. Foundation of treatment
• Psychology: Cognitive-behavioral therapy, pain education, anxiety/depression management, family therapy
• Family-based intervention: Educating parents about pain mechanisms, reducing protective/avoidant behaviors, supporting return to function
• School reintegration: Coordinated plan for gradual return to school attendance and academic engagement
• Pharmacological support: Low-dose neuromodulatory agents to facilitate engagement with rehabilitation

Avoid: Extended rest, excessive investigations, multiple specialist referrals without coordination, opioid analgesics, repeated imaging.

Initial assessment priorities:

• Detailed pain history: onset, characteristics, distribution, relationship to activities
• Exclusion of organic disease with targeted investigations and imaging
• Psychosocial assessment: anxiety, depression, trauma history, school impact, family factors
• Functional assessment: activities of daily living, mobility, school attendance
• Assessment for depression, anxiety, post-traumatic stress requiring urgent attention

Avoid immobilization: Early mobilization and functional activity are essential. Reassurance about benign nature of condition is critical.

Outcome measures: School attendance, functional capacity (mobility, self-care, recreation), pain severity, depression/anxiety scores, quality of life indices.

Monitor medication tolerance: Amitriptyline side effects (dry mouth, drowsiness), duloxetine efficacy for mood symptoms.

Post-trauma CRPS: AMPS following injury or surgery. Prognosis better with early intensive rehabilitation. Distinguish from normal recovery by disproportionate symptoms and functional limitation.

Concurrent mental health conditions: Depression, anxiety, and PTSD are common comorbidities requiring integrated treatment. Psychological intervention must be prominent component of care.

Adolescents: May have additional psychosocial stressors (peer relationships, school pressure, identity development). Requires age-appropriate psychological approaches.

Multiple presentations: Some children develop pain in multiple regions sequentially. Early intervention in initial presentation may prevent chronicity and spread.

Investigation stewardship: Limit investigations to those needed for diagnosis and exclusion of organic disease. Repeated investigations reinforce illness behavior and delay recovery. Once diagnosis established, ongoing imaging and blood work are not indicated.

Medication stewardship: Amitriptyline is first-line pharmacotherapy; NSAIDs and paracetamol are adjunctive only. Avoid opioids completely. Duloxetine reserved for significant mood comorbidity requiring treatment. Simple analgesics should NOT delay engagement with rehabilitation.

Specialist stewardship: Coordinate interdisciplinary care through single point of contact. Multiple uncoordinated specialist referrals increase health anxiety and delay recovery. Establish care team (primary physician, physiotherapist, psychologist) working collaboratively.

Avoid: Opioid analgesics, extended rest/immobilization, repeated investigations, fragmented specialist care, reassurance-seeking reinforcement.

Prognosis with early intervention: Children with AMPS treated with intensive interdisciplinary intervention within 3-6 months of symptom onset have excellent prognosis, with 60-80% achieving substantial functional recovery.

Long-standing disease: Duration >1 year at presentation associated with more guarded prognosis. Disability and school avoidance become entrenched. Still responsive to intensive intervention but recovery takes longer.

Transition to adulthood: Children with AMPS entering adolescence require ongoing monitoring. Psychological factors and social stressors may need adjustment of management. Ensure transition to adult pain medicine services if symptoms persist.

Relapse prevention: After achieving remission, gradual return to full prior activities important. Provide strategies to prevent relapse triggered by new injury, stress, or illness. Brief psychological booster sessions may be protective.

Monitoring for complications: Watch for residual functional limitation, chronic anxiety/depression, over-medicalization of other health symptoms, social isolation.

• American Academy of Pediatrics: Complex Regional Pain Syndrome in children and adolescents
• International Association for the Study of Pain (IASP): CRPS classification and diagnosis criteria
• Pediatric Pain Society: Evidence-based guidelines for AMPS management
• Australian Rheumatology Association: Chronic pain syndromes in children — interdisciplinary management
• eTG - Therapeutic Guidelines: Chronic pain management in children